Based on the findings in DNA microarray analysis in control AR-positive vs. AR-knockdown bladder cancer sublines we had previously performed [24], we anticipated that GABBR2 functioned as a downstream target of AR. The gene discussed is GABBR2; the disease is urinary bladder carcinoma.